The largest database of trusted experimental protocols

Anti cd31 clone jc70a

Manufactured by Agilent Technologies
Sourced in United States

Anti-CD31 (clone JC70A) is a laboratory reagent used for the identification and quantification of cells expressing the CD31 (platelet endothelial cell adhesion molecule-1, PECAM-1) antigen. It is commonly used in immunohistochemical and flow cytometric applications.

Automatically generated - may contain errors

9 protocols using anti cd31 clone jc70a

1

Immunohistochemical Staining of Tumor Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the evaluation of MCDPT, MCAPT, MVD, and EA, a three-layer biotin-avidin-peroxidase system was utilized [17 (link)]. Briefly, 4 μm thick serial sections of formalin-fixed and paraffin-embedded surgically removed tumour samples were deparaffinised. Then, for antigen retrieval, sections were microwaved at 500 W for 10 min, after which endogenous peroxidase activity was blocked with 3% hydrogen peroxide solution. Next, adjacent slides were incubated with the monoclonal antibodies anti-CD31 (clone JC70a; Dako) diluted 1 : 40 for 30 min at room temperature and anti-tryptase (clone AA1; Dako, Glostrup, Denmark) diluted 1 : 100 for 1 h at room temperature. The bound antibody was visualised using biotinylated secondary antibody, avidin-biotin peroxidase complex, and fast red. Nuclear counterstaining was performed with Gill's haematoxylin number 2 (Polysciences, Warrington, PA, USA). Primary antibody was omitted in negative controls.
+ Open protocol
+ Expand
2

Immunohistochemistry Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical studies were performed on formalin-fixed, paraffin-embedded sections as previously described [19 (link), 40 (link)], or in a Dako AutoStainer (Dako, Carpinteria, CA). Antibodies used include: anti-CD68 (clone PG-M1, Dako, dilution 1:100); anti-CD163 (clone10D6, Biocare Medical, Concord, CA, USA, dilution 1:50); anti-CD31 (clone JC70A, Dako, ready-to use); anti-MMP-9 (clone Ab-2, Oncogene Research Products Cambridge, MA, dilution 1:50); and anti E-cadherin (Dako, clone NCH-38, ready to use).
+ Open protocol
+ Expand
3

Multiplex Immunofluorescence Analysis of Breast Cancer Tumor Microenvironment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed paraffin embedded patient tissue from 5 invasive ductal carcinomas was collected under the Montefiore-Einstein IRB approval. Paraffin embedded human breast cancer tumors were cut to 5 μm sections, deparaffinized and stained for H&E or TMEM. The sequence was anti-CD31 (clone JC70A, DAKO, Carpinteria, CA) and Vector Blue chromogen (for endothelial cells); anti CD-68 (clone PG-M1; DAKO) with and DAB chromogen (for macrophages); and anti-pan-Mena with Fast Red chromogen (for carcinoma cells) (8 (link), 11 (link)). Sequential sections were cut for tyramide signal amplification (TSA) for quantitative immunofluorescence using the Opal 3-plex Kit (Perkin Elmer) according to manufacturer’s directions. The sequence was rabbit anti-VEGF (1:2000, Rb 9031-P0-A, Thermo) with TSA Plus Cy3; rabbit anti-Tie2 (1:3000, clone C-20, Santa Cruz Biotech) with TSA Plus Cy5; goat anti-VE-cadherin (1:200, clone C-19, Santa Cruz Biotech) with TSA Plus fluorescein and nuclei stained with 4,6-diamidino-2-phenylindole (DAPI). All quantitative analysis was performed on the raw 16-bit TIFF images and images of TMEM were validated independently by a pathologist.
+ Open protocol
+ Expand
4

Histological Evaluation of Wound Healing

Check if the same lab product or an alternative is used in the 5 most similar protocols
All specimens were stained with hematoxylin and eosin (H&E), Elastica van Gieson, von Kossa, and Masson‐Trichrome (CoverStainer for H&E and ArtisanLink for other stains; Dako). In addition, immunohistochemical staining was performed using the following antibodies: anti‐CD68 (Clone KP1; Dako), anti‐CD10 (Clone 56C6; Novocastra), anti‐CD31 (Clone JC70A; Dako), and anti‐α‐smooth muscle actin (Clone 1A4; Dako). Stained slides were scanned using Aperio Scan Scope and imaged with Aperio Image Scope (Leica Biosystems). H&E‐stained slides were prepared to obtain a general overview over the tissue and to evaluate the thickness of the epidermis and dermis and re‐epithelialization of the wound bed. Von Kossa‐stained slides were used to evaluate the presence of calcification. Elastica van Gieson‐stained slides were used to evaluate the presence of elastic fibres and collagen. Masson trichrome staining was performed for the histological visualisation of collagen and identification of collagen subtypes. The amount of mature collagen within the wound area was assessed in a semi‐quantitatively manner by scoring for a substantial amount of collagen, a moderate amount of collagen, a low amount of collagen, or no collagen. The biopsies were analysed in a paired fashion: PCT‐treated wounds were compared to SoC‐treated wounds at V9 and to initial skin biopsies taken at V2 (Figure S2).
+ Open protocol
+ Expand
5

Comprehensive Immunohistochemical Profiling of Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formaldehyde-fixed and paraffin-embedded tumors were sectioned to 2 µm, following de-waxing, peroxidase blocking and antigen-retrieval using EDTA buffer. Detection of CD271, CD31, Ki67, S100, vimentin, MITF, HMB45 and MART1/MLANA was performed with anti-CD271 (clone D4B3, XP, Cell signaling), anti-CD31 (clone JC/70A, Dako), anti-Ki67 (clone MIB1, Dako), anti-S100 (clone 15E2/E2, BioGenex), anti-vimentin (clone V9, Dako), anti-MITF (clones C5 + D5, Zytomed), anti-melanosom (clone HMB45, Dako) or anti-MART1 (clone A103, Dako) with an automated staining system (BenchMark Ultra, Ventana Medical Systems, USA). Histological staining was performed with hematoxylin/eosin (H&E, Merck). Immunohistochemical staining of two antigens was performed with the DakoCytomation kit (Dako).
+ Open protocol
+ Expand
6

Immunohistochemical Analysis of Vascular Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Slices of 3 μm were analyzed. For CD31 and CD34 analysis, dewaxing, hydration, and thermal unmasking of the antigen were conducted with the DAKO PT Link module and with a high-pH solution (EnVisionTMFLEX Target Retrieval Solution, High pH, K8004). For CD105 analysis, which required enzymatic digestion to expose antigenic determinants, dewaxing, hydration, and unmasking were done manually, and proteinase K (DAKO, S3020) was used (5 min, room temperature). The following primary antibodies were used: anti-CD31 (clone JC70A, Ready-to-Use, DAKO IR610), anti-CD34 (clone QBEnd 10, Ready-to-Use, DAKO IR632), and anti-CD105 (clone SN6h, 1:20, DAKO M3527). EnVisionTM FLEX/HRP (DAKO SM802), containing peroxidase and secondary antibodies were used for detection. Diaminobenzidine (EnVisionTM FLEX DAB+ Chromogen, DAKO DM827) was employed for secondary antibody visualization. Contrast staining with hematoxylin was employed.
+ Open protocol
+ Expand
7

Immunohistochemical Analysis of Synovial Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
ST were routinely fixed and embedded in paraffin. Deparaffinized sections were cooked to perform antigen retrieval when required. Slides were subsequently stained with an automated immunostainer (TechMate 500 Plus; Dako, Cambridge, UK) using the following monoclonal antibodies: anti-CD3 (clone PS1; Novocastra, Newcastle, UK) for T-lymphocytes, anti-CD20 (clone L26; Dako) for B-lymphocytes, anti-CD68 (clone KP-1; Dako) for CD68 + macrophages, anti-CD117 (rabbit anti-human polyclonal antibody; Dako) for mast cells, anti-Hsp47 monoclonal antibodies (IgG2b M16.10A1 clone; Assay Designs) for synovial fibroblasts, anti-CD31 (clone JC70A; Dako) for endothelial cells, and anti-basic fibroblast growth factor (bFGF) (polyclonal SC-79, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-CXCL12 (clone K15C [22 (link)]) for angiogenic markers, which were significantly increased in serum from these patients in our previous study [20 (link)]. As a negative control, the primary antibodies were substituted by isotype-matched and concentration-matched control antibodies. The primary antibodies were subsequently detected by an avidin-biotin-peroxidase-based method (Envision System; Dako) and an aminoethylcarbazole color reaction (Sigma-Aldrich, St. Louis, MO, USA) as previously described [23 (link)]. Finally, the slides were counterstained with hematoxylin.
+ Open protocol
+ Expand
8

Immunohistochemical Analysis of Formalin-Fixed Tissue Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed 4 μm sections were deparaffinised with xylene and rehydrated through graded ethanol and demineralised water. Antigens were retrieved by boiling in 10 mM citrate buffer, pH 6.0 in a pressure cooker. Non-specific binding was blocked using Antibody Diluent S2022 (Dako). Consecutive tissue sections were incubated with the following primary monoclonal mouse anti-human antibodies diluted in Antibody Diluent S2022 (Dako): anti-TF (No. 4509, American Diagnostica), anti-Epithelial Membrane Antigen (MUC1) (clone E29), anti-CD68 (clone KP1) and anti-CD31 (Clone JC70A) from Dako. After blocking endogenous peroxidases, staining was visualised using a peroxidase-labelled polymer conjugated to goat anti-mouse immunoglobulins and 3,3′-diaminobenzidine (K4007, Mouse EnVision+ kit, Dako). Sections were decolourised, counterstained with haematoxylin (1 : 1 dilution with demineralised water; Merck, Darmstadt, Germany), decolourised again, dehydrated and finally permanently mounted.
Mouse IgG1 (BD Biosciences) and omission of the primary antibody served as specificity controls. Normal pancreatic islet cells, tonsils and ductal breast cancer cells served as positive control for TF, CD68 and MUC1 staining, respectively. No separate control was prepared for CD31 staining.
+ Open protocol
+ Expand
9

Hypoxia Evaluation in Rabbit Aorta

Check if the same lab product or an alternative is used in the 5 most similar protocols
On the day of the final imaging session, the hypoxia marker pimonidazole hydrochloride (60 mg/kg; Hypoxyprobe Inc.) was injected intravenously 2 hours before euthanizing the animals. After imaging, rabbits were euthanized and the aorta was fixed overnight in 10% buffered-formalin. Serial sections (5-μm thick) were obtained and stained with hematoxylin-eosin. Additional serial sections were assessed for hypoxia, macrophages, neovessels and HIF-1α using mouse monoclonal antibodies against pimonidazole (MAb1, Hypoxyprobe Inc.), anti-rabbit macrophage (clone RAM-11, Dako), anti-CD31 (clone JC70A, Dako), and anti-HIF-1α (clone H1α67, Novus Biologicals), respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!